Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) - Global Forecast to 2027
Updated on : May 22, 2023
The global patient engagement solutions market in terms of revenue was estimated to be worth $17.3 billion in 2022 and is poised to reach $27.9 billion by 2027, growing at a CAGR of 10% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The factors driving the growth of this market are implementation of changing government regulations and healthcare initiatives to promote patient-centric care, high demand for patient engagement solutions in the post pandemic era, and the growing utilization of m-health apps.However, interoperability for patient engagement solutions and a shortage of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
Patient Engagement Solutions Market Dynamics
Driver: Implementation of government regulations and initiatives to promote patient-centric care
In March 2020, the US President signed a USD 2 million coronavirus emergency stimulus package called the CARES (Coronavirus Aid, Relief, and Economic Security) Act. The law expands cover treatment and services for those affected by COVID-19. The CARES Act also increases flexibility for Medicare to cover telehealth services; authorizes Medicare certification for home health services by physician assistants, nurse practitioners, and certified nurse specialists; and increases Medicare payments for COVID-19-related hospital stays and durable medical equipment. Such initiatives/regulations are expected to increase further the demand and adoption of patient engagement solutions in major markets worldwide.
Restraint: Large investment requirements for healthcare infrastructure
Payers have made substantial investments in infrastructure and proprietary systems in the past. Moving or integrating these systems with patient engagement solutions will pose various challenges to these organizations in terms of cost. It will also require changes to their current systems that are optimized to handle only their current requirements. Also, the move to cloud-based patient engagement solutions would involve changing the current IT architecture, especially in hospitals that already serve as hubs connecting multiple physicians, labs, and pharmacists. Hence, finding the resources to achieve large-scale interoperability and interconnectivity could hamper the transition to cloud-based patient engagement solutions for such healthcare institutions.
Challenge: High deployments costs of healthcare IT systems
Healthcare IT systems have high-priced software solutions.The maintenance and software update costs of these systems may be more than the software price. Support and maintenance services along with software upgrades , represent a recurring expenditure, which amounts to almost 30% of the total cost of ownership. The lack of internal skilled IT professionals in the healthcare industry necessitates training for end users to increase the efficiency and results of various healthcare IT solutions, thereby adding to the cost of ownership of the systems. Evaluating information systems in healthcare can also be challenging as the organizational impact & benefits of IT systems in healthcare are often intangible.
Opportunity: Growth opportunities in emerging markets
Several factors, such as adopting government initiatives that support the adoption of HCIT solutions, rising government expenditure on healthcare facilities, and the presence of skilled IT experts in emerging Asian countries, such as China and India, are expected to support the growth of the global market in the APAC region. Technological advancements play a key role in reforming the country’s healthcare management sector. China is currently facing challenges such as underfunded rural health centers, overburdened city hospitals, and a nationwide shortage of doctors.
North America accounted for the largest share of the global patient engagement solutions market.
North America accounted for the largest share of this market. Government regulations supporting the healthcare system, the need to reduce healthcare costs for better accessibility, the rising prevalence of chronic diseases, and the majority of key market players operating in the region are the key factors driving the growth of the market in North America.
To know about the assumptions considered for the study, download the pdf brochure
Some of the key players operating in patient engagement solutions market are IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and Patient point LLC (US)
Patient Engagement Solutions Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$17.3 billion |
|
Estimated Value by 2027 |
$27.9 billion |
|
Revenue Rate |
Poised to grow at a CAGR of 10.0% |
|
Market Driver |
Implementation of government regulations and initiatives to promote patient-centric care< |
|
Market Opportunity |
Growth opportunities in emerging economies |
The study categorizes the global patient engagement solutions market to forecast revenue and analyze trends in each of the following submarkets:
By Component
- Hardware
- Software
- Standalone Software
- Integrated Software
- Services
By Delivery Mode
- PREMISE Mode
- CLOUD-BASED Mode
By Application
- Health management
- Home health management
- Social
- Financial health management
By Therapeutic Area
- Chronic diseases
- Cardiovascular diseases (CVD)
- Diabetes
- Obesity
- Other chronic diseases
- Women’s health
- Fitness
- Other Therapeutic Areas
By Functionality
- Introduction
- E-Prescribing
- Virtual Consultation
- Patient/Client Scheduling
- Document Management
By End User
- Providers
- Payers
- Patients
- Other End users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
-
ROW
- Latin America
- Middle East & Africa
Recent Developments:
- In 2021, McKesson (US) announced a strategic agreement with Merck (US) that enables the two healthcare leaders to harness the power of real-world evidence (RWE) toward the common goal of improving patient outcomes and the quality of cancer care.
- In 2021, Humana (US) collaborated with IBM (US) to deploy IBM Watson Assistant for Health Benefits; it is an AI-enabled virtual agent built in the IBM Watson Health Cloud. This agent helps provide a better member experience while providing greater clarity and transparency on benefits and other related matters for Humana Employer Group members.
- In 2021, Allied Digestive Health (ADH) selected athenahealth’s (US) cloud-based healthcare payments and patient engagement solutions to drive patient relations and revenue cycle excellence, thus supporting the organization’s growth in the coming years.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global patient engagement solutions market?
The global patient engagement solutions market boasts a total revenue value of $27.9 billion by 2027.
What is the estimated growth rate (CAGR) of the global patient engagement solutions market?
The global patient engagement solutions market has an estimated compound annual growth rate (CAGR) of 10% and a revenue size in the region of $17.3 billion in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.5.1 SCOPE-RELATED LIMITATIONS
1.5.2 METHODOLOGY-RELATED LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.2 PRIMARY SOURCES
2.2.1 KEY INDUSTRY INSIGHTS
2.2.2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 2 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.4 MARKET ESTIMATION
2.4.1 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.4.2 APPROACH: END USER-BASED MARKET ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.4.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
2.4.4 GLOBAL MARKET: TOP-DOWN APPROACH
2.4.5 GROWTH FORECAST
FIGURE 4 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE LABORATORY INFORMATICS MARKET (2022–2027)
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.5 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: GLOBAL MARKET
2.8 LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022 VS. 2027
FIGURE 8 GLOBAL MARKET, BY DELIVERY MODE, 2022 VS. 2027
FIGURE 9 GLOBAL MARKET, BY APPLICATION, 2022 VS. 2027
FIGURE 10 GLOBAL MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027
FIGURE 11 GLOBAL MARKET, BY FUNCTIONALITY, 2022 VS. 2027
FIGURE 12 GLOBAL MARKET, BY END USER, 2022 VS. 2027
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 51)
4.1 GLOBAL MARKET OVERVIEW
FIGURE 14 RISING GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE DRIVE THE MARKET GROWTH
4.2 GLOBAL MARKET, BY END USER
FIGURE 15 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL MARKET IN 2021
4.3 NORTH AMERICA: MARKET, BY DELIVERY MODE & COUNTRY (2021)
FIGURE 16 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
4.4 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
FIGURE 17 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
5.2.1.2 Increasing adoption of patient engagement solutions
5.2.1.3 Rising number of collaborations and partnerships between stakeholders
TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
5.2.1.4 Increasing utilization of mobile health apps
5.2.2 RESTRAINTS
5.2.2.1 Large investment requirements for healthcare infrastructure
5.2.2.2 Protection of patient information
5.2.2.3 Inadequate interoperability across healthcare providers
5.2.2.4 Shortage of skilled IT professionals in the healthcare industry
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging markets
5.2.3.2 Wearable health technology
5.2.3.3 Cloud-computing solutions
5.2.4 CHALLENGES
5.2.4.1 High deployments costs of healthcare IT systems
5.2.4.2 Low levels of healthcare literacy
5.3 IMPACT OF COVID-19 ON THE GLOBAL MARKET
5.4 CASE STUDIES
5.4.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE
5.4.1.1 Case 1: Need to reduce patient hospital stays
5.4.2 IMPROVE OUTPATIENT COMMUNICATION
5.4.2.1 Case 2: Rising need to curb miscommunication with discharged patients
5.4.3 PATIENT ENGAGEMENT STRATEGY
5.4.3.1 Case 3: Post-discharge care
5.5 ECOSYSTEM ANALYSIS
FIGURE 19 GLOBAL MARKET: ECOSYSTEM ANALYSIS
5.6 TECHNOLOGY ANALYSIS
TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.7 REGULATORY ANALYSIS
5.7.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
5.7.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
5.7.6 AFFORDABLE CARE ACT, 2010
5.8 PRICING ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PATIENT ENGAGEMENT SOLUTION MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10 INDUSTRY TRENDS
5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE
6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT (Page No. - 70)
6.1 INTRODUCTION
TABLE 5 GLOBAL MARKET, BY COMPONENT, 2020–2027
6.2 HARDWARE
6.2.1 HARDWARE SOLUTIONS ARE AN INTERACTIVE EXPERIENCE FOR PATIENTS & FAMILIES
TABLE 6 HARDWARE MARKET, BY REGION, 2020–2027
6.3 SOFTWARE
TABLE 7 SOFTWARE MARKET, BY REGION, 2020–2027
TABLE 8 SOFTWARE MARKET, BY TYPE, 2020–2027
6.3.1 STANDALONE SOFTWARE
6.3.1.1 Standalone software refers to the traditional software installed in client systems
TABLE 9 STANDALONE SOFTWARE MARKET, BY REGION, 2020–2027
6.3.2 INTEGRATED SOFTWARE
6.3.2.1 Reduction in time spent on data management is driving the growth of this segment
TABLE 10 INTEGRATED SOFTWARE MARKET, BY REGION, 2020–2027
6.4 SERVICES
6.4.1 THE SERVICES SEGMENT IS EXPECTED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
TABLE 11 SERVICES MARKET, BY REGION, 2020–2027
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE (Page No. - 76)
7.1 INTRODUCTION
TABLE 12 GLOBAL MARKET, BY DELIVERY MODE, 2020–2027
7.2 ON-PREMISE MODE
7.2.1 PATIENT DATA SAFETY AND COST BENEFITS OF ON-PREMISE DELIVERY MODES TO DRIVE THE MARKET GROWTH
TABLE 13 ON-PREMISE MODE MARKET, BY REGION, 2020–2027
7.3 CLOUD-BASED MODE
7.3.1 REGULATORY REQUIREMENTS HAVE DRIVEN HEALTHCARE PROVIDERS TO ADOPT CLOUD-BASED SOLUTIONS
TABLE 14 CLOUD-BASED MODE MARKET, BY REGION, 2020–2027
8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION (Page No. - 80)
8.1 INTRODUCTION
TABLE 15 GLOBAL MARKET, BY APPLICATION, 2020–2027
8.2 HEALTH MANAGEMENT
8.2.1 HEALTH MANAGEMENT PLAYS A CRUCIAL TOOL IN GUIDING PATIENTS IN SELF-CARE
TABLE 16 GLOBAL MARKET FOR HEALTH MANAGEMENT, BY REGION, 2020–2027
8.3 HOME HEALTH MANAGEMENT
8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT THE MARKET GROWTH
TABLE 17 GLOBAL MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2020–2027
8.4 SOCIAL & BEHAVIORAL MANAGEMENT
8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE THE MARKET GROWTH
TABLE 18 GLOBAL MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2020–2027
8.5 FINANCIAL HEALTH MANAGEMENT
8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS
TABLE 19 GLOBAL MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2020–2027
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA (Page No. - 85)
9.1 INTRODUCTION
TABLE 20 GLOBAL MARKET, BY THERAPEUTIC AREA, 2020–2027
9.2 CHRONIC DISEASES
TABLE 21 GLOBAL MARKET FOR CHRONIC DISEASES, BY REGION, 2020–2027
TABLE 22 GLOBAL MARKET FOR CHRONIC DISEASES, BY TYPE, 2020–2027
9.2.1 CARDIOVASCULAR DISEASES (CVD)
9.2.1.1 CVD is the leading cause of death worldwide
TABLE 23 GLOBAL MARKET FOR CVD, BY REGION, 2020–2027
9.2.2 DIABETES
9.2.2.1 The high incidence of diabetes worldwide drives the growth of this segment
TABLE 24 GLOBAL MARKET FOR DIABETES, BY REGION, 2020–2027
9.2.3 OBESITY
9.2.3.1 Rising prevalence of obesity to drive the growth of this segment
TABLE 25 GLOBAL MARKET FOR OBESITY, BY REGION, 2020–2027
9.2.4 OTHER CHRONIC DISEASES
TABLE 26 GLOBAL MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2020–2027
9.3 WOMEN’S HEALTH
9.3.1 INCREASING SELF AWARENESS FOR THE MANAGEMENT OF DISEASES TO DRIVE THE MARKET GROWTH
TABLE 27 GLOBAL MARKET FOR WOMEN’S HEALTH, BY REGION, 2020–2027
9.4 FITNESS
9.4.1 GROWING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT THE MARKET GROWTH FOR FITNESS-RELATED APPS
TABLE 28 GLOBAL MARKET FOR FITNESS, BY REGION, 2020–2027
9.5 OTHER THERAPEUTIC AREAS
TABLE 29 GLOBAL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2020–2027
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY (Page No. - 93)
10.1 INTRODUCTION
TABLE 30 GLOBAL MARKET, BY FUNCTIONALITY, 2020–2027
10.1.1 E-PRESCRIBING
10.1.1.1 E-prescribing is a cost-effective method of providing valuable information to clinicians to enhance decision-making
TABLE 31 GLOBAL MARKET FOR E-PRESCRIBING, BY REGION, 2020–2027
10.1.2 VIRTUAL CONSULTATION
10.1.2.1 Telehealth provides flexibility in treatment options due to remote monitoring
TABLE 32 GLOBAL MARKET FOR VIRTUAL CONSULTATION, BY REGION, 2020–2027
10.1.3 PATIENT/CLIENT SCHEDULING
10.1.3.1 Patient/client scheduling enables physicians to streamline workflows and efficiently manage patient schedules
TABLE 33 GLOBAL MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2020–2027
10.1.4 DOCUMENT MANAGEMENT
10.1.4.1 The effective management of patient documents is crucial for healthcare providers
TABLE 34 GLOBAL MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2020–2027
11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER (Page No. - 98)
11.1 INTRODUCTION
TABLE 35 GLOBAL MARKET, BY END USER, 2020–2027
11.2 PROVIDERS
11.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
TABLE 36 GLOBAL MARKET FOR PROVIDERS, BY REGION, 2020–2027
11.3 PAYERS
11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE PAYERS MINIMIZE ERRORS
TABLE 37 GLOBAL MARKET FOR PAYERS, BY REGION, 2020–2027
11.4 PATIENTS
11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS TO MONITOR & IMPROVE HEALTH OUTCOMES
TABLE 38 GLOBAL MARKET FOR PATIENTS, BY REGION, 2020–2027
11.5 OTHER END USERS
TABLE 39 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2020–2027
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION (Page No. - 103)
12.1 INTRODUCTION
TABLE 40 GLOBAL MARKET, BY REGION, 2020–2027
12.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: MARKET SNAPSHOT
TABLE 41 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027
TABLE 42 NORTH AMERICA: MARKET, BY COMPONENT, 2020–2027
TABLE 43 NORTH AMERICA: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 44 NORTH AMERICA: MARKET, BY END USER, 2020–2027
TABLE 45 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027
TABLE 46 NORTH AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027
TABLE 47 NORTH AMERICA: MARKET, BY FUNCTIONALITY, 2020–2027
12.2.1 US
12.2.1.1 The US is the largest market in North America for patient engagement solutions in 2022
TABLE 48 US: MARKET, BY COMPONENT, 2020–2027
TABLE 49 US: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 50 US: MARKET, BY END USER, 2020–2027
TABLE 51 US: MARKET, BY APPLICATION, 2020–2027
TABLE 52 US: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.2.2 CANADA
12.2.2.1 Growing need for cost containment to propel the market growth in Canada
TABLE 53 CANADA: MARKET, BY COMPONENT, 2020–2027
TABLE 54 CANADA: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 55 CANADA: MARKET, BY END USER, 2020–2027
TABLE 56 CANADA: MARKET, BY APPLICATION, 2020–2027
TABLE 57 CANADA: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.3 EUROPE
TABLE 58 EUROPE: MARKET, BY COUNTRY, 2020–2027
TABLE 59 EUROPE: MARKET, BY COMPONENT, 2020–2027
TABLE 60 EUROPE: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 61 EUROPE: MARKET, BY END USER, 2020–2027
TABLE 62 EUROPE: MARKET, BY APPLICATION, 2020–2027
TABLE 63 EUROPE: MARKET, BY THERAPEUTIC AREA, 2020–2027
TABLE 64 EUROPE: MARKET, BY FUNCTIONALITY, 2020–2027
12.3.1 GERMANY
12.3.1.1 Germany is the largest market for patient engagement solutions in Europe in 2022
TABLE 65 GERMANY: MARKET, BY COMPONENT, 2020–2027
TABLE 66 GERMANY: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 67 GERMANY: MARKET, BY END USER, 2020–2027
TABLE 68 GERMANY: MARKET, BY APPLICATION, 2020–2027
TABLE 69 GERMANY: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.3.2 FRANCE
12.3.2.1 Digital health insurance startups in France to drive the market growth for patient engagement solutions
TABLE 70 FRANCE: MARKET, BY COMPONENT, 2020–2027
TABLE 71 FRANCE: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 72 FRANCE: MARKET, BY END USER, 2020–2027
TABLE 73 FRANCE: MARKET, BY APPLICATION, 2020–2027
TABLE 74 FRANCE: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.3.3 UK
12.3.3.1 Favorable government initiatives to promote healthcare to support market growth in the UK
TABLE 75 UK: MARKET, BY COMPONENT, 2020–2027
TABLE 76 UK: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 77 UK: MARKET, BY END USER, 2020–2027
TABLE 78 UK: MARKET, BY APPLICATION, 2020–2027
TABLE 79 UK: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.3.4 SPAIN
12.3.4.1 Data security concerns restrict the market growth in Spain
TABLE 80 SPAIN: MARKET, BY COMPONENT, 2020–2027
TABLE 81 SPAIN: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 82 SPAIN: MARKET, BY END USER, 2020–2027
TABLE 83 SPAIN: MARKET, BY APPLICATION, 2020–2027
TABLE 84 SPAIN: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.3.5 ITALY
12.3.5.1 The growing burden of chronic diseases in Italy drives the demand for patient engagement solutions
TABLE 85 ITALY: MARKET, BY COMPONENT, 2020–2027
TABLE 86 ITALY: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 87 ITALY: MARKET, BY END USER, 2020–2027
TABLE 88 ITALY: MARKET, BY APPLICATION, 2020–2027
TABLE 89 ITALY: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.3.6 REST OF EUROPE (ROE)
TABLE 90 ROE: MARKET, BY COMPONENT, 2020–2027
TABLE 91 ROE: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 92 ROE: MARKET, BY END USER, 2020–2027
TABLE 93 ROE: MARKET, BY APPLICATION, 2020–2027
TABLE 94 ROE: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 95 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027
TABLE 96 ASIA PACIFIC: MARKET, BY COMPONENT, 2020–2027
TABLE 97 ASIA PACIFIC: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 98 ASIA PACIFIC: MARKET, BY END USER, 2020–2027
TABLE 99 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027
TABLE 100 ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2020–2027
TABLE 101 ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2020–2027
12.4.1 JAPAN
12.4.1.1 The rising geriatric population in Japan supports the market growth for patient engagement solutions
TABLE 102 JAPAN: MARKET, BY COMPONENT, 2020–2027
TABLE 103 JAPAN: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 104 JAPAN: MARKET, BY END USER, 2020–2027
TABLE 105 JAPAN: MARKET, BY APPLICATION, 2020–2027
TABLE 106 JAPAN: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.4.2 CHINA
12.4.2.1 Implementation of EMR solutions in healthcare by the Chinese government is expected to drive the demand for patient engagement solutions
TABLE 107 CHINA: MARKET, BY COMPONENT, 2020–2027
TABLE 108 CHINA: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 109 CHINA: MARKET, BY END USER, 2020–2027
TABLE 110 CHINA: MARKET, BY APPLICATION, 2020–2027 USD MILLION)
TABLE 111 CHINA: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.4.3 INDIA
12.4.3.1 High burden of chronic diseases to support the market growth for patient engagement solutions
TABLE 112 INDIA: MARKET, BY COMPONENT, 2020–2027
TABLE 113 INDIA: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 114 INDIA: MARKET, BY END USER, 2020–2027
TABLE 115 INDIA: MARKET, BY APPLICATION, 2020–2027
TABLE 116 INDIA: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 117 ROAPAC: MARKET, BY COMPONENT, 2020–2027
TABLE 118 ROAPAC: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 119 ROAPAC: MARKET, BY END USER, 2020–2027
TABLE 120 ROAPAC: MARKET, BY APPLICATION, 2020–2027
TABLE 121 ROAPAC: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.5 REST OF THE WORLD
TABLE 122 REST OF THE WORLD: MARKET, BY REGION, 2020–2027
TABLE 123 ROW: MARKET, BY COMPONENT, 2020–2027
TABLE 124 ROW: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 125 ROW: MARKET, BY END USER, 2020–2027
TABLE 126 ROW: MARKET, BY APPLICATION, 2020–2027
TABLE 127 ROW: MARKET, BY THERAPEUTIC AREA, 2020–2027
TABLE 128 ROW: MARKET, BY FUNCTIONALITY, 2020–2027
12.5.1 LATIN AMERICA
12.5.1.1 Developments in healthcare infrastructure to support the market growth
TABLE 129 LATIN AMERICA: MARKET, BY COMPONENT, 2020–2027
TABLE 130 LATIN AMERICA: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 131 LATIN AMERICA: MARKET, BY END USER, 2020–2027
TABLE 132 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027
TABLE 133 LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027
12.5.2 MIDDLE EAST & AFRICA
12.5.2.1 Rising government support to drive the market growth for patient engagement solutions in the MEA
TABLE 134 MIDDLE EAST & AFRICA: MARKET, BY COMPONENT, 2020–2027
TABLE 135 MIDDLE EAST & AFRICA: MARKET, BY DELIVERY MODE, 2020–2027
TABLE 136 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027
TABLE 137 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2027
TABLE 138 MIDDLE EAST & AFRICA: MARKET, BY THERAPEUTIC AREA, 2020–2027
13 COMPETITIVE LANDSCAPE (Page No. - 150)
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE MARKET
13.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN THE GLOBAL MARKET
13.4 MARKET RANKING
FIGURE 23 GLOBAL MARKET RANKING, BY KEY PLAYER, 2021
13.5 COMPETITIVE BENCHMARKING
TABLE 139 GLOBAL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 140 GLOBAL MARKET: DETAILED LIST OF KEY STARTUP/SMES
13.6 COMPETITIVE LEADERSHIP MAPPING
13.6.1 STARS
13.6.2 EMERGING LEADERS
13.6.3 PERVASIVE PLAYERS
13.6.4 PARTICIPANTS
FIGURE 24 GLOBAL MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
13.7 COMPETITIVE LEADERSHIP MAPPING – START-UP/SME
13.7.1 PROGRESSIVE COMPANIES
13.7.2 STARTING BLOCKS
13.7.3 RESPONSIVE COMPANIES
13.7.4 DYNAMIC COMPANIES
FIGURE 25 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
13.8 COMPETITIVE SITUATIONS AND TRENDS
13.8.1 PRODUCT LAUNCHES
13.8.2 DEALS
14 COMPANY PROFILES (Page No. - 166)
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 IBM
TABLE 141 IBM: BUSINESS OVERVIEW
FIGURE 26 IBM: COMPANY SNAPSHOT (2021)
14.1.2 MCKESSON CORPORATION
TABLE 142 MCKESSON CORPORATION: BUSINESS OVERVIEW
FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
14.1.3 ALLSCRIPTS HEALTHCARE SOLUTIONS INC
TABLE 143 ALLSCRIPTS HEALTHCARE SOLUTIONS INC: BUSINESS OVERVIEW
FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
14.1.4 ATHENAHEALTH
TABLE 144 ATHENAHEALTH: BUSINESS OVERVIEW
14.1.5 ORION HEALTH
TABLE 145 ORION HEALTH: BUSINESS OVERVIEW
14.1.6 CERNER CORPORATION
TABLE 146 CERNER: BUSINESS OVERVIEW
FIGURE 29 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
TABLE 147 GETWELL NETWORK INC: BUSINESS OVERVIEW
14.1.8 LINCOR SOLUTIONS
TABLE 148 LINCOR SOLUTIONS: BUSINESS OVERVIEW
14.1.9 COGNIZANT
TABLE 149 COGNIZANT: BUSINESS OVERVIEW
FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2020)
14.1.10 HARRIS HEALTHCARE
TABLE 150 HARRIS HEALTHCARE: BUSINESS OVERVIEW
14.2 OTHER KEY PLAYERS
14.2.1 GET REAL HEALTH
14.2.2 ONEVIEW HEALTHCARE
14.2.3 ADVANCEDMD
14.2.4 EPIC SYSTEMS CORPORATION
14.2.5 MEDITECH
14.2.6 KAREO
14.2.7 ECLINICAL WORKS
14.2.8 WELLSTACK
14.2.9 IQVIA
14.2.10 VIVIFY HEALTH
14.2.11 MEDHOST
14.2.12 VALIDIC
14.2.13 CUREMD HEALTHCARE
14.2.14 MEDISYSINC.COM
14.2.15 PATIENTPOINT, LLC
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX (Page No. - 204)
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 AVAILABLE CUSTOMIZATIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Patient Engagement Solutions market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study include publications from government sources, such as WHO, ATA, AHA and AAHM. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, Payers- Private and Public Insurance Bodies, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and the Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Patient Engagement Solutions Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the global market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research.
- The revenue generated from the sale of patient engagement solutions products by leading players has been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the patient engagement solutions market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market
Report Objectives
- To define, describe, and forecast the global patient engagement solutions market based on component, delivery mode, application, therapeutic area, functionality, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure and profile the key players of the market and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
- To track and analyze competitive developments such as product launches, acquisitions, partnerships, agreements, and collaborations in the patient engagement solutions market during the forecast period
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Company information
- Detailed analysis and profiling of additional market players (up to 20)
Generating Response ...
Growth opportunities and latent adjacency in Patient Engagement Solutions Market
What will be the value for the global Patient Engagement Solutions Market in 2030?
Which of the geographical segment holds the major share of the Patient Engagement Solutions Market?